Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Likelihood of inadequate treatment: a novel approach to evaluating drug-resistance patterns.

Burgmann H, Stoiser B, Heinz G, Schenk P, Apfalter P, Zedtwitz-Liebenstein K, Frass M, Carmeli Y.

Infect Control Hosp Epidemiol. 2009 Jul;30(7):672-7. doi: 10.1086/598245.

PMID:
19496644
2.

[Guidelines for treatment of pneumonia in intensive care units].

Emmi V.

Infez Med. 2005;Suppl:7-17. Review. Italian.

3.

Management of antibiotic resistance in the intensive care unit setting.

Petrosillo N, Capone A, Di Bella S, Taglietti F.

Expert Rev Anti Infect Ther. 2010 Mar;8(3):289-302. doi: 10.1586/eri.10.7. Review.

PMID:
20192683
4.

[Diagnostic and therapeutic management of Gram-negative infections].

Bassetti M, Repetto E.

Infez Med. 2008 Apr;16 Suppl2:22-9. Review. Italian.

5.

Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation.

Bassetti M, Villa G, Pecori D.

Future Microbiol. 2014;9(4):465-74. doi: 10.2217/fmb.14.7. Review.

PMID:
24810346
6.

Pseudomonas aeruginosa: evolution of antimicrobial resistance and implications for therapy.

McCarthy K.

Semin Respir Crit Care Med. 2015 Feb;36(1):44-55. doi: 10.1055/s-0034-1396907. Epub 2015 Feb 2. Review.

PMID:
25643270
7.

[Calculated antibiotic therapy in gastroenterologic infections].

Braun RW.

Praxis (Bern 1994). 2003 Aug 13;92(33):1343-9. Review. German.

PMID:
14502790
8.

Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria.

Kidd JM, Kuti JL, Nicolau DP.

Expert Opin Pharmacother. 2018 Mar;19(4):397-408. doi: 10.1080/14656566.2018.1438408. Epub 2018 Feb 19. Review.

PMID:
29411661
9.

Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.

Monogue ML, Kuti JL, Nicolau DP.

Expert Rev Clin Pharmacol. 2016;9(3):459-76. doi: 10.1586/17512433.2016.1133286. Epub 2016 Jan 16. Review.

PMID:
26678036
10.

Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress.

Molyneux EM, Dube Q, Newberry L.

Curr Opin Infect Dis. 2015 Jun;28(3):215-20. doi: 10.1097/QCO.0000000000000162. Review.

PMID:
25887608
11.

Challenges and opportunities in the treatment of ventilator-associated pneumonia.

Schreiber MP, Shorr AF.

Expert Rev Anti Infect Ther. 2017 Jan;15(1):23-32. Epub 2016 Oct 31. Review.

PMID:
27771978
12.
13.

An Argument for the Use of Aminoglycosides in the Empiric Treatment of Ventilator-Associated Pneumonia.

May AK.

Surg Infect (Larchmt). 2016 Jun;17(3):329-33. doi: 10.1089/sur.2015.276. Epub 2016 Apr 1. Review.

PMID:
27035615
14.

Antibiotic stewardship: the lower-extremity physician's prescription for effectively treating infection.

Smith RG, Joseph WS.

J Am Podiatr Med Assoc. 2014 Jan-Feb;104(1):77-84. Review.

PMID:
24504581
15.

Aerosolized antibiotics: do they add to the treatment of pneumonia?

Kollef MH, Hamilton CW, Montgomery AB.

Curr Opin Infect Dis. 2013 Dec;26(6):538-44. doi: 10.1097/QCO.0000000000000004. Review.

16.

Research and development of antibiotics: insights from patents and citation network.

Zhang M, Kong X, Zheng J, Wan JB, Wang Y, Hu Y, Shao R.

Expert Opin Ther Pat. 2016 May;26(5):617-27. doi: 10.1517/13543776.2016.1167877. Epub 2016 Apr 6. Review.

PMID:
26986226
17.

Microbiological conclusions.

Jones RN.

Drugs. 1991;42 Suppl 3:22-4. Review. No abstract available.

PMID:
1726204
18.

Expert systems in clinical microbiology.

Winstanley T, Courvalin P.

Clin Microbiol Rev. 2011 Jul;24(3):515-56. doi: 10.1128/CMR.00061-10. Review.

19.

[Maximal (de-escalation) empiric therapy of life threatening infections at hospital].

Iakovlev SV.

Antibiot Khimioter. 2002;47(3):37-43. Review. Russian. No abstract available.

PMID:
16127906

Supplemental Content

Support Center